Tesamorelin, CJC-1295 (no DAC), and Ipamorelin is a research peptide blend formulated to investigate growth hormone axis modulation through combined GHRH and ghrelin receptor pathways. Tesamorelin and CJC-1295 (Mod GRF 1–29) activate GHRH receptor signaling via cAMP/PKA cascades, while Ipamorelin targets the GHS-R1a receptor, promoting calcium mobilization. This blend is used in endocrine and receptor biology studies exploring synergistic GH pulsatility and hypothalamic–pituitary coordination.
